Form 4: Insmed Inc. CEO William Lewis Reports Acquisition of Shares and Stock Options

William Lewis, Chair and CEO of Insmed Inc., reports the acquisition of restricted stock units and stock options, along with adjustments to his beneficial ownership.

Summary

• On May 15, 2025, William Lewis, the Chair and CEO of Insmed Inc., acquired 22,314 shares of common stock in the form of Restricted Stock Units (RSUs) and 108,380 stock options.
• The RSUs vest 25% on the first day of the month following the first anniversary of the grant date, and then 25% annually thereafter.
• The stock options also vest, with 25% vesting on the initial vesting date and an additional 12.5% vesting every six months thereafter.
• Following these transactions, Lewis directly owns 335,287 shares of common stock.
• He also has indirect ownership through the Katie Procter Dynasty Trust (233,924 shares) and the William Lewis Family Legacy Trust (50,500 shares).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock transactions by an executive. The acquisition of shares and options could be interpreted as a positive signal, but it's a routine event.

Positives

• The acquisition of RSUs and stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.

Stakeholder Impact

• The reported transactions may have a minor impact on shareholder sentiment, potentially signaling confidence from the CEO.

Key Dates

Keywords

Insmed Inc, William Lewis, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Options, Insider Trading